130 results
Page 2 of 7
6-K
EX-99.1
bnc vrcztobtz
11 Dec 23
Biophytis announces its participation in several conferences in Europe and the US during the first quarter of 2024
12:18pm
6-K
EX-99.1
sghvujt
5 Dec 23
Current report (foreign)
6:04am
6-K
EX-99.1
hl7 gwf6h1
28 Nov 23
Biophytis appoints Yann Meunier and Bernard Lévy to its Scientific Advisory Board
10:47am
6-K
EX-99.1
8fk3pzidzrzm7otln5ik
21 Nov 23
Biophytis announces receipt of Nasdaq Notice
11:37am
6-K
EX-99.1
6jrl1
7 Nov 23
Current report (foreign)
12:45pm
6-K
EX-99.1
34gsp
2 Nov 23
Biophytis and Innovation Solutions Pharma sign a partnership agreement to accelerate market access for Sarconeos (BIO101) in Brazil
2:44pm
6-K
EX-99.1
lpw2z2e4hgo9b hziy
27 Oct 23
Biophytis receives notice of delisting from Nasdaq and announces it will request a hearing before the Nasdaq Hearings Panel
5:15pm
6-K
EX-99.1
ceetfe2ow6jbv
28 Sep 23
Current report (foreign)
10:18am
6-K
EX-99.1
7afj5aohrkg42p4r
20 Sep 23
Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19
6:02am
6-K
EX-99.1
jwuj8pd
14 Sep 23
Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
11:03am
6-K
EX-99.1
vusgcoilm 25y67pkp
11 Sep 23
Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia
9:52am
6-K
EX-99.1
58knv8cfe06s9zdd
5 Sep 23
Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York
9:12am
6-K
EX-99.1
e7js vzz8f5vvd7o
25 Aug 23
Biophytis receives a positive opinion for its SARA-31
12:29pm
6-K
EX-99.1
g52 zc94hizs66
25 Aug 23
Biophytis announces next regulatory steps in Europe
12:21pm
6-K
EX-10.2
34ro16ro
21 Jul 23
Biophytis Announces $3.8 Million
6:01am
6-K
EX-10.1
2y6s02tj7gk2p 4afmc
21 Jul 23
Biophytis Announces $3.8 Million
6:01am
6-K
EX-99.1
e572cubp
21 Jul 23
Biophytis Announces $3.8 Million
6:01am
424B5
3p52l4bvlrw gncw42k
20 Jul 23
Prospectus supplement for primary offering
5:27pm
6-K
EX-99.1
kjpvycr6 gx4ssl
20 Jul 23
Current report (foreign)
11:35am
6-K
EX-99.1
vwol q2j44459
19 Jul 23
Biophytis Announces $3.8 Million
10:26am